Get started
Author

Yuan Wu

A Survey on Data Contamination for Large Language Models
2025 · Cheng, Yuxing, Chang, Yi, et al. · arXiv (Cornell University) · 79
PDF
Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
2019 · Jun Lu, Yu Xu, et al. · BMC Cancer · 54
PDF
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
2025 · Cheng Xu, Guan-Qun Zhou, et al. · Cancer Cell · 51
An inverse association between tea consumption and colorectal cancer risk
2017 · Yuetong Chen, Yuan Wu, et al. · Oncotarget · 47
PDF
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial
2025 · The DIAMOND Study Group, Cheng Xu, et al. · JAMA · 39
Dietary methionine restriction alleviates oxidative stress and inflammatory responses in lipopolysaccharide-challenged broilers at early age
2023 · Xiyuan Pang, Zhiqiang Miao, et al. · Frontiers in Pharmacology · 24
PDF
Prognostic significance of combined Lymphocyte-monocyte Ratio and Tumor-associated Macrophages in Gastric Cancer Patients after Radical Resection
2020 · Bin-bin Xu, Yu Xu, et al. · Journal of Cancer · 16
PDF
Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter study
2022 · Yan Zhang, Junying Xu, et al. · Annals of Translational Medicine · 11
PDF
Genetic variants in p53 signaling pathway genes predict chemotherapy efficacy in colorectal cancer
2019 · Ke Zhang, Yixuan Meng, et al. · Cancer Medicine · 7
PDF
TBX2 Expression predicts Tumor Recurrence and Adjuvant Chemotherapy Benefits in Gastric Cancer Patients following R0 Resection: a proposed approach for risk stratification
2020 · Jun Lu, Yu Xu, et al. · Journal of Cancer · 5
PDF
Effects of the MAML2 genetic variants in glioma susceptibility and prognosis
2019 · Ming Zhang, Yonglin Zhao, et al. · Bioscience Reports · 4
Genetic variants in CYP4F2 were significantly correlated with susceptibility to ischemic stroke
2019 · Yuan Wu, Junjie Zhao, et al. · BMC Medical Genetics · 3
PDF
Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancer
2018 · Deqiang Wang, Xiaomei Zhang, et al. · OncoTargets and Therapy · 3
PDF
P3.18.39 PRESERVE-003: A Phase 3 Study of Gotistobart Versus Docetaxel in Metastatic NSCLC After Progression on PD-(L)1 Inhibitors
2025 · T. Li, Y. Wu, et al. · Journal of Thoracic Oncology · 1
Effectiveness and safety of disitamab vedotin (RC48) in pretreated HER2-positive advanced breast cancer: A real-world experience in China.
2024 · Yiqun Li, De Zeng, et al. · Journal of Clinical Oncology · 1
670P Preliminary efficacy and safety of tinengotinib (TT-00420) monotherapy in Chinese patients (pts) with advanced solid tumors: Results from a phase Ib/II study
2023 · P. Zhang, J. Gong, et al. · Annals of Oncology · 1
Anlotinib combined with etoposide as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): Updated results from a phase II trial.
2022 · Bo Shen, Yuan Wu, et al. · Journal of Clinical Oncology
P48.24 Anlotinib Combined with Etoposide as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
2021 · B. Shen, Y. Wu, et al. · Journal of Thoracic Oncology
PDF
Genetic Variants in the p53 Signaling Pathway Genes Predict Chemotherapy Efficacy for Colorectal Cancer
2018 · Ke Zhang, Yixuan Meng, et al. · SSRN Electronic Journal
Works count: 19
Citation count: 346
H-index: 8
I10-index: 8
Year
Topic
Type